产品特点
Issued: March 2013
AN: 01883/2011
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Marfloquin 20 mg tablets for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Marbofloxacin…….20 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Light brownish yellow, round, biconvex, marble tablets with bevelled edges and with
possible dark and white spots, scored on one side.
The tablets can be divided into halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by strains of microorganisms susceptible to
marbofloxacin in dogs:
skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis,
furunculosis, cellulitis);
urinary tract infections (UTI) associated or not with prostatitis or epididymitis;
respiratory tract infections.
4.3
CONTRAINDICATIONS
Do not use in dogs aged less than 12 months, or less than 18 months for
exceptionally large breeds of dogs, such as Great Danes, Briard, Bernese, Bouvier
and Mastiffs, with a longer growth period.
Do not use in cats. For the treatment of this species, a 5 mg tablet is available.
Do not use in animals with known hypersensitivity to marbofloxacin or other
(fluoro)quinolones or to any of the excipients of the product.
Issued: March 2013
AN: 01883/2011
Page 2 of 6
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
A low urinary pH could have an inhibitory
阅读完整的文件